Money Lancer
← Equity: Sectoral-Pharma and Healthcare
ITI Mutual Fund
ITI Mutual Fund · Equity: Sectoral-Pharma and Healthcare

ITI Pharma And Healthcare Fund - Regular Plan - Growth Option

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

EquityBenchmark · Nifty Healthcare TRITER · 2.62%Inception · 08-11-2021
NAV
₹17.05
-1.02% · as of 14-10-2026
Since inception
11.42%
CAGR
Benchmark (inception)
14.55%
CAGR
Fund size
₹266 Cr
AUM
Expense ratio
2.62%
29-09-2026
Performance

Returns vs benchmark & category

Since inception: +11.42% CAGR vs benchmark +14.55%.

Portfolio

Where the money is invested

Top holdings

SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-13.34%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-6.79%
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-6.22%
Dr. Reddys Laboratories Ltd5.44%
MAX HEALTHCARE INSTITUTE LIMITED EQ5.41%
CIPLA LIMITED EQ NEW FV RS.2/-4.60%
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-4.56%
LAURUS LABS LIMITED EQ NEW FV RS. 2/-4.40%
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-4.10%
LUPIN LIMITED EQ NEW F.V. RS.2/-3.30%

Sector allocation

Healthcare92.31%
Capital Goods2.71%
Chemicals1.25%
Financial Services0.51%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 11.4% p.a.
₹10,000
10 years
Projected value
₹22,44,793
Invested: ₹12,00,000
Gained: ₹10,44,793
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
M
Mr. Animesh Singh and Mr. Nilay Dalal
Manager since fund inception data not available
ISIN & identifiers
AMFI code
149270
ISIN (Growth)
INF00XX01BL5
ISIN (Div Re-inv)
—
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us